bioaccess® — The First CRO Specifically Designed for First-in-Human Clinical Trials Healthcare startups creating innovative MedTech devices, Biopharma treatments, and Radiopharma solutions encounter a significant obstacle: the need to produce clinical data that investors and buyers require before th
$50,000+
Min Project Size
10-49
Employees
“bioaccess® is a pioneering CRO specializing in first-in-human clinical trials for healthcare startups, offering accelerated, cost-effective, and regulatory-compliant clinical development across MedTech, Biopharma, and Radiopharma sectors.”













